2025 Annual Meeting | S18 - Paraneoplastic Neurological Disorders, irAE, Stiff Person, IGLON5
Program Materials Program Evaluations
| Mar Guasp, MD | Dr. Guasp has nothing to disclose. |
| Amanda L. Piquet, MD, FAAN | The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Novartis. The institution of Dr. Piquet has received research support from Abbvie. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities. |
| Samantha Banks, MD | Dr. Banks has nothing to disclose. |
| Charles L. Howe, PhD | Dr. Howe has received personal compensation for serving as an employee of Mayo Clinic. The institution of Dr. Howe has received research support from NIH/NINDS. |
| Sean J. Pittock, MD, FAAN | Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Andrew McKeon, MD | The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |
| Eoin P. Flanagan, MBBCh, FAAN | The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. |
| Divyanshu Dubey, MD, FAAN | The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. |
| Cristina Valencia Sanchez, MD | Dr. Valencia Sanchez has a non-compensated relationship as a member of the medical advisory board with The MOG Project that is relevant to AAN interests or activities. |
| Smathorn Thakolwiboon, MD | Dr. Thakolwiboon has nothing to disclose. |
| Jessica A. Sagen, MA | Ms. Sagen has nothing to disclose. |
| Farwa Ali, MD | Dr. Ali has nothing to disclose. |
| Anastasia Zekeridou, MD, PhD, FAAN | The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. |
| Giovanni Di Liberto, MD, PhD | Dr. Di Liberto has nothing to disclose. |
| Kristof Egervari, MD, PhD | Dr. Egervari has nothing to disclose. |
| Alberto Vogrig, MD, PhD | Alberto Vogrig has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai. Alberto Vogrig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini. The institution of Alberto Vogrig has received research support from Ministero della Salute, Bando Ricerca Finalizzata. |
| Marianna Spatola, MD, PhD | The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation. |
| Margot Piccinno, Jr., Doctoral Student | Mrs. Piccinno has nothing to disclose. |
| Ilena Vincenti, PhD | Dr. Vincenti has nothing to disclose. |
| ingrid wagner, technician | Mrs. wagner has nothing to disclose. |
| Mario Kreutzfeldt, PhD | Dr. Kreutzfeldt has nothing to disclose. |
| Verena Endmayr, PhD | Dr. Endmayr has nothing to disclose. |
| Karoline D. Ostertag, MD | Dr. Ostertag has nothing to disclose. |
| Jasmin Rahimi | Dr. Rahimi has nothing to disclose. |
| Alex Vicino | No disclosure on file |
| Anne-Katrin Proebstel, MD | The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Proebstel has received research support from Biogen. Dr. Proebstel has received intellectual property interests from a discovery or technology relating to health care. |
| David Meyronet | No disclosure on file |
| Stephan Frank, MD | Prof. Frank has nothing to disclose. |
| Marco Prinz, MD | Prof. Prinz has nothing to disclose. |
| Ekkehard Hewer, MD | Prof. Hewer has nothing to disclose. |
| Jean-Philippe Brouland | No disclosure on file |
| Laura Parkkinen, PhD | The institution of Prof. Parkkinen has received research support from GSK. The institution of Prof. Parkkinen has received research support from NIH. The institution of Prof. Parkkinen has received research support from NIHR Oxford Biomedical Research Centre. |
| Bogdan Draganski, MD | Prof. Draganski has nothing to disclose. |
| Virginie Desestret | Virginie Desestret has nothing to disclose. |
| Shanu Roemer | Shanu Roemer has nothing to disclose. |
| Dennis W. Dickson, MD | Dr. Dickson has nothing to disclose. |
| Romana Hoeftberger | Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with Euroimmun and UCB Biopharma. |
| Sarosh R. Irani, MD, PhD, FRCP, FEAN | Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB, Immunovant, MedImmun, Roche, Janssen, Cerebral therapeutics, Biogen, Amgen, Argenex, Clarivate, IQVIA, BioHaven therapeutics, ADC therapeutics, Brain, CSL Behring, and ONO Pharma.. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. |
| Jerome Honnorat, MD, PhD | The institution of Jerome Honnorat, MD, PhD has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for journal of neurology. |
| Renaud A. Du Pasquier, MD, FAAN | Dr. Du Pasquier has nothing to disclose. |
| Doron Merkler, MD | Prof. Merkler has nothing to disclose. |
| Macarena Villagran-Garcia, MD | Dr. Villagran-Garcia has received research support from Fundación Martín Escudero. |
| Valentin Wucher, PhD | Mr. Wucher has nothing to disclose. |
| Caleigh Mandel-Brehm, PhD | The institution of Dr. Mandel-Brehm has received research support from NIH-NINDS K99/R00 grant. Dr. Mandel-Brehm has received intellectual property interests from a discovery or technology relating to health care. |
| Antonio Farina | Mr. Farina has nothing to disclose. |
| John Pluvinage, MD, PhD | Dr. Pluvinage has received research support from National Institute on Aging. |
| Laetitia CADET, BSc | Ms. CADET has nothing to disclose. |
| Anne-Laurie Pinto | Anne-Laurie Pinto has nothing to disclose. |
| Sergio Muniz-Castrillo, MD, PhD | Dr. Muniz-Castrillo has nothing to disclose. |
| Amna Abichou, PhD | Mrs. Abichou has nothing to disclose. |
| GERALDINE PICARD, MSc | Mrs. PICARD has nothing to disclose. |
| Veronique Rogemond, PhD | Mrs. Rogemond has nothing to disclose. |
| Michael R. Wilson, MD, FAAN | Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cambridge Medical Experts. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. The institution of Dr. Wilson has received research support from Chan Zuckerberg Initiative. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice. |
| Joseph DeRisi, PhD | Joseph DeRisi, PhD has received personal compensation for serving as an employee of Chan Zuckerberg Biohub. Joseph DeRisi, PhD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allen & Co. Joseph DeRisi, PhD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Public Health Company, Inc. Joseph DeRisi, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for Delve Bio. Joseph DeRisi, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for VeriPhi Inc. The institution of Joseph DeRisi, PhD has received research support from Chan Zuckerberg Biohub. Joseph DeRisi, PhD has received intellectual property interests from a discovery or technology relating to health care. |
| Marie Benaiteau, MD | Dr. Benaiteau has nothing to disclose. |
| Birzu Cristina, MD | Dr. Cristina has nothing to disclose. |
| Dimitri Psimaras, MD | No disclosure on file |
| pauline dumez, MD | Dr. dumez has nothing to disclose. |
| Marie Rafiq, MD | Dr. Rafiq has nothing to disclose. |
| Bastien Joubert | Bastien Joubert has nothing to disclose. |
| Nimalan Harinesan, MBBS | Dr. Harinesan has nothing to disclose. |
| Ehab Y. Harahsheh, MBBS | Dr. Harahsheh has nothing to disclose. |
| Albert Aboseif, DO | Dr. Aboseif has a non-compensated relationship as a AAN Autoimmune Neurology Section -- 好色先生 Workgroup with AAN that is relevant to AAN interests or activities. |
| Sepideh Mokhtari, MD | Dr. Mokhtari has nothing to disclose. |
| Rajesh K. Gupta, MBBS | Dr. Gupta has nothing to disclose. |
| Simone Nicholson | Simone Nicholson has received personal compensation for serving as an employee of Biohaven. Simone Nicholson has stock in Biohaven. |
| Elizabeth Dierks | Elizabeth Dierks has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Elizabeth Dierks has stock in Biohaven Pharmaceuticals. Elizabeth Dierks has stock in Bristol-Myers Squibb. |
| Wes Kazmierski | Wes Kazmierski has received personal compensation for serving as an employee of Biohaven Phamaceuticals. Wes Kazmierski has stock in Biohaven Pharmaceuticals. Wes Kazmierski has received intellectual property interests from a discovery or technology relating to health care. |
| Chuck Poole | Mr. Poole has received personal compensation for serving as an employee of Allucent . |
| Gene Dubowchik | Gene Dubowchik has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gene Dubowchik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Foerster. |
| David Pirman | David Pirman has received personal compensation for serving as an employee of Biohaven. David Pirman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scaffold Tx. David Pirman has stock in Agios. |
| David Spiegel | David Spiegel has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Biohaven. David Spiegel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Magnet Biotherapeutics. David Spiegel has stock in Biohaven. David Spiegel has stock in Magnet Biotherapeutics. The institution of David Spiegel has received research support from Biohaven. David Spiegel has received intellectual property interests from a discovery or technology relating to health care. |
| Anna Bunin | Dr. Bunin has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Bunin has stock in Biohaven Pharmaceuticals. Dr. Bunin has received intellectual property interests from a discovery or technology relating to health care. |
| Neal Sharpe | Neal Sharpe has nothing to disclose. |
| Vlad Coric | No disclosure on file |
| Bruce D. Car | Dr. Car has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Car has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PathAI. Dr. Car has stock in BHVN. Dr. Car has received intellectual property interests from a discovery or technology relating to health care. |
| Jackie Weiss, PhD | Dr. Weiss has received personal compensation for serving as an employee of EUROIMMUN US. |
| Ramona Miske | Ramona Miske has received personal compensation for serving as an employee of Euroimmun. Ramona Miske has received intellectual property interests from a discovery or technology relating to health care. |
| Madeleine Scharf, PhD | Dr. Scharf has received personal compensation for serving as an employee of Euroimmun AG. |
| Kathrin Borowski | Mrs. Borowski has nothing to disclose. |
| Ina Specht | No disclosure on file |
| Merle Corty | No disclosure on file |
| Monika-Johanna Lortiz | No disclosure on file |
| Frederik Rombach | No disclosure on file |
| Guy Laureys, MD, PhD | The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. |
| Nadine Rochow | Mrs. Rochow has received personal compensation for serving as an employee of Euroimmun. |
| Christiane Radzimski, PhD | Dr. Radzimski has received personal compensation for serving as an employee of EUROIMMUN AG. |
| Linda Schnitter | No disclosure on file |
| Dominica Ratuszny | No disclosure on file |
| Thomas Skripuletz | Thomas Skripuletz has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Alnylam Pharmaceuticals, Biogen, Centogene, CSL Behring, Grifols, Hexal AG, Janssen-Cilag, Merck Serono, Novartis, Roche, Sanofi, Swedish Orphan Biovitrum, Viatris. Thomas Skripuletz has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for from Alexion, Alnylam Pharmaceuticals, argenx, Bayer Vital, Biogen, Bristol Myers Squibb, Celgene, Centogene, CSL Behring, Euroimmun, Grifols, Hexal AG, Horizon, Janssen-Cilag, Merck Serono, Novartis, Pfizer, Roche, Sanofi, Siemens, Swedish Orphan Biovitrum, Teva, Viatris. |
| Mike Wattjes | No disclosure on file |
| Stefanie Hahn | No disclosure on file |
| Yvonne Denno | No disclosure on file |
| Khadija Guerti, MD | Dr. Guerti has nothing to disclose. |
| Matthijs U. Oyaert, Sr., PhD | Dr. Oyaert has nothing to disclose. |
| Farid Benkhadra | No disclosure on file |
| Corinna Bien | No disclosure on file |
| Sophie Nitsch | No disclosure on file |
| Klaus Peter Wandinger, MD | Prof. Wandinger has nothing to disclose. |
| Vincent Van Pesch, MD, PhD | Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Vincent Van Pesch, MD, PhD has received research support from Biogen. |
| Christian Probst | No disclosure on file |
| Bianca Teegen | No disclosure on file |
| Lars Komorowski | Lars Komorowski has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for EUROIMMUN . Lars Komorowski has stock in Revvity. Lars Komorowski has received intellectual property interests from a discovery or technology relating to health care. |
| Kurt-Wolfram Suhs | Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Kurt-Wolfram Suhs has received research support from Bristol Myers Squibb. |
| Shuvro Roy, MD | Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| Yujie Wang, MD | Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wang has received research support from Genentech. The institution of Dr. Wang has received research support from uniQure. The institution of Dr. Wang has received research support from NIH/NINDS. |
| Scott D. Newsome, DO, FAAN | Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from The Stiff Person Syndrome Research Foundation. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche. |
| Kathryn Fitzgerald, PhD | The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society. |
| Yishang Huang, research data anlayst | Miss Huang has nothing to disclose. |
| Chen Hu | Chen Hu has nothing to disclose. |
| Jeremias Motte, MD | The institution of Prof. Motte has received research support from Ruhr-Univerity Bochum. |
| Rafael M. Klimas | Mr. Klimas has nothing to disclose. |
| Melissa Sgodzai | Melissa Sgodzai has nothing to disclose. |
| Franziska T. Wunsch, MD | Ms. Wunsch has nothing to disclose. |
| Charmaine Schücke, MSc | Miss Schücke has nothing to disclose. |
| Min-Suk Yoon, MD | No disclosure on file |
| Anna Lena Fisse | Dr. Fisse has stock in Novartis. Dr. Fisse has stock in Novo Nordisk. |
| Anke Salmen | The institution of Anke Salmen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuraxpharm. Anke Salmen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Anke Salmen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Anke Salmen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuraxpharm. Anke Salmen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Anke Salmen has received research support from Regional association of the German MS Society (DMSG Landesverband NRW). |
| Dominic Borie | Dominic Borie has received personal compensation for serving as an employee of Kyverna Therapeutics. Dominic Borie has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Kyverna Therapeutics. Dominic Borie has stock in Kyverna. |
| Aiden Haghikia, MD | Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. The institution of Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyverna. Dr. Haghikia has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Biogen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Celgene. |
| Kalliopi Pitarokoili, MD | Dr. Pitarokoili has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. |
| Roland Schroers | Roland Schroers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KYVERNA. |
| Ralf Gold, MD | Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen. |
| Advait Padhye, MBMSCI | Mr. Padhye has received personal compensation for serving as an employee of Percheron Therapeutics . Mr. Padhye has received intellectual property interests from a discovery or technology relating to health care. |
| Xinli Xu | Mrs. Xu has nothing to disclose. |
| Yufang Yan | Dr. Yan has nothing to disclose. |
| JINGQI HUANG, MD | Dr. HUANG has nothing to disclose. |
| George Tachas, PhD | Dr. Tachas has stock in Percheron Therapeutic. Dr. Tachas has received personal compensation in the range of $100,000-$499,999 for serving as a Principal Scientist with Percheron Therapeutics Ltd. |
| James S. Garner, MBBS, MBA | Dr. Garner has received personal compensation for serving as an employee of Percheron Therapeutics Limited. Dr. Garner has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Percheron Therapeutics Limited. Dr. Garner has stock in Percheron Therapeutics Limited. Dr. Garner has received intellectual property interests from a discovery or technology relating to health care. |